INSMED INC Unamortized Debt Issuance Expense
INSMED INC (INSM) had Unamortized Debt Issuance Expense of $261.00 thousand as of 2017-12-31, per its 10-K filed 2018-02-23.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2018-02-23
- 2017-12-31: Unamortized Debt Issuance Expense $261.00K.
- 2016-12-31: Unamortized Debt Issuance Expense $380.00K.
- 2016-06-30: Unamortized Debt Issuance Expense $175.00K.
- 2016-03-31: Unamortized Debt Issuance Expense $212.00K.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2017-12-31 | $261.00K 10-K · filed 2018-02-23 |
| 2016-12-31 | $380.00K 10-K · filed 2017-02-23 |
| 2016-06-30 | $175.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $212.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $250.00K 10-K · filed 2016-02-25 |
| 2015-09-30 | $77.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $154.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $231.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $308.00K 10-K · filed 2015-02-27 |
| 2014-09-30 | $202.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $247.00K 10-Q · filed 2014-08-06 |
| 2014-03-31 | $179.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $215.00K 10-K · filed 2014-03-06 |
| 2013-09-30 | $140.00K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $144.00K 10-Q · filed 2013-08-06 |
| 2013-03-31 | $169.00K 10-Q · filed 2013-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |